Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens
- 15 January 2012
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 377 (1-2) , 23-36
- https://doi.org/10.1016/j.jim.2011.12.010
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced MelanomaNew England Journal of Medicine, 2011
- Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen‐specific CD4+ T cellsClinical and Experimental Allergy, 2011
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerNew England Journal of Medicine, 2010
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationProceedings of the National Academy of Sciences, 2010
- Simultaneous detection of many T-cell specificities using combinatorial tetramer stainingNature Methods, 2009
- Dendritic cell vaccination and immune monitoringCancer Immunology, Immunotherapy, 2008
- GM-CSF/IL-3/IL-5 receptor common β chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cellsJournal of Translational Medicine, 2008
- Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificitiesBlood, 2007
- Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expressionNature Protocols, 2006
- Direct access to CD4+ T cells specific for defined antigens according to CD154 expressionNature Medicine, 2005